INTESTINE MICROBIOLOGY

Randomised clinical trial of synbiotic therapy in elective surgical patients

A D G Anderson, C E McNaught, P K Jain, J MacFie

Combined Gastroenterology Research Group, Scarborough Hospital, Woodlands Drive, Scarborough, UK

Correspondence to:
Correspondence to:
Mr J MacFie
Scarborough Hospital, Woodlands Drive, Scarborough, YO12 6QL, UK; Johnmacfie{at}aol.com

Background: It is possible to manipulate the composition of the gastrointestinal microflora by administration of pre- and probiotics. This may help to preserve gut barrier function and reduce the incidence of septic morbidity.

Aims: To assess the effects of a combination of pre- and probiotics (synbiotic) on bacterial translocation, gastric colonisation, systemic inflammation, and septic morbidity in elective surgical patients.

Patients: Patients were enrolled two weeks prior to elective abdominal surgery. Seventy two patients were randomised to the synbiotic group and 65 to the placebo group. Patients were well matched regarding age and sex distribution, diagnoses, and POSSUM scores.

Methods: Patients in the synbiotic group received a two week preoperative course of Lactobacillus acidophilus La5, Bifidobacterium lactis Bb-12, Streptococcus thermophilus, and Lactobacillus bulgaricus, together with the prebiotic oligofructose. Patients in the placebo group received placebo capsules and sucrose powder. At surgery, a nasogastric aspirate, mesenteric lymph node, and scrapings of the terminal ileum were harvested for microbiological analysis. Serum was collected preoperatively and on postoperative days 1 and 7 for measurement of C reactive protein, interleukin 6, and antiendotoxin antibodies. Septic morbidity and mortality were recorded.

Results: There were no significant differences between the synbiotic and control groups in bacterial translocation (12.1% v 10.7%; p = 0.808, ²), gastric colonisation (41% v 44%; p = 0.719), systemic inflammation, or septic complications (32% v 31%; p = 0.882).

Conclusions: In this study, synbiotics had no measurable effect on gut barrier function in elective surgical patients. Further studies investigating the place of pre- and probiotics in clinical practice are required.

Keywords: prebiotics; probiotics; synbiotics; bacterial translocation

Abbreviations: CRP, C reactive protein; IL-6, interleukin 6; IgM EndoCAb, antiendotoxin core antibody; POSSUM score, physiological and operative severity scores for enumeration of morbidity; IQR, interquartile range

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Robin Spiller
Gut 2004 53: 159. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Guarner, F. (2007). Studies with Inulin-Type Fructans on Intestinal Infections, Permeability, and Inflammation. J. Nutr. 137: 2568S-2571S [Abstract] [Full Text]  
• Isakow, W., Morrow, L. E., Kollef, M. H. (2007). Probiotics for Preventing and Treating Nosocomial Infections: Review of Current Evidence and Recommendations. Chest 132: 286-294 [Abstract] [Full Text]  
• Alberda, C., Gramlich, L., Meddings, J., Field, C., McCargar, L., Kutsogiannis, D., Fedorak, R., Madsen, K. (2007). Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 85: 816-823 [Abstract] [Full Text]  
• Luyer, M. D., Buurman, W. A., Hadfoune, M., Speelmans, G., Knol, J., Jacobs, J. A., Dejong, C. H. C., Vriesema, A. J. M., Greve, J. W. M. (2005). Strain-Specific Effects of Probiotics on Gut Barrier Integrity following Hemorrhagic Shock. Infect. Immun. 73: 3686-3692 [Abstract] [Full Text]  
• Bengmark, S., Martindale, R. (2005). Prebiotics and Synbiotics in Clinical Medicine. Nutr Clin Pract 20: 244-261 [Abstract] [Full Text]